Simplifying Global Compliance
Hospira Healthcare India Pvt. - July 1, 2016
The list of observations noted below document that the Quality Unit has not performed the necessary assessments/reviews to ensure that the objectionable conditions do not negatively affect the aseptic manufacturing processes and Quality Control tests in support of the finished sterile drug products.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing